succinylcholine has been researched along with labetalol in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Avramov, MN; Husain, MM; Stool, LA; White, PF | 1 |
Angel, JJ; Bush, AJ; Lawson, P; Ramanathan, J; Sibai, B | 1 |
1 review(s) available for succinylcholine and labetalol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for succinylcholine and labetalol
Article | Year |
---|---|
Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Intravenous; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Electroconvulsive Therapy; Electroencephalography; Glycopyrrolate; Heart Rate; Humans; Infusions, Intravenous; Injections, Intravenous; Labetalol; Methohexital; Middle Aged; Muscarinic Antagonists; Neuromuscular Depolarizing Agents; Nicardipine; Placebos; Prospective Studies; Seizures; Succinylcholine | 1998 |
3 other study(ies) available for succinylcholine and labetalol
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Changes in maternal middle cerebral artery blood flow velocity associated with general anesthesia in severe preeclampsia.
Topics: Adult; Anesthesia, General; Anesthetics, Intravenous; Antihypertensive Agents; Blood Flow Velocity; Blood Pressure; Cerebral Arteries; Cerebrovascular Circulation; Cesarean Section; Female; Heart Rate; Humans; Injections, Intravenous; Intubation, Intratracheal; Labetalol; Neuromuscular Depolarizing Agents; Pre-Eclampsia; Pregnancy; Prospective Studies; Regression Analysis; Succinylcholine; Thiopental; Ultrasonography, Doppler, Transcranial | 1999 |